Wiley General Catalog
Find a Wiley book:
(enter title, Editor, or keywords)

Wiley InterScience
Find a Wiley journal:
(enter title words)



WILEY REFERENCE SERIES IN BIOSTATISTICS
Biostatistics in Clincal Trials

Editors: 
Carol K. Redmond, University of Pittsburgh, USA
Theodore Colton, Boston University, USA

Main Page for this Work
Table of Contents
About the Editors
Sample Articles

Also available:
A landmark reference for the medical and health sciences...

Encyclopedia of Biostatistics


Features over 70 articles covering a wide 
and diverse range of topics . . .


650 pages
ISBN: 0471 82211 6
Hardcover
Published: March 2001

CONTENTS

Adaptive and dynamic methods of treatment assignment 
Antibacterial agent trials 
Audit and quality control 
Bayesian methods 
Benefit/risk assessment 
Blinding or masking 
Clinical significance versus statistical significance 
Clinical trials, overview 
Cluster randomization 
Cochrane collaboration 
Community intervention trials 
Compliance assessment 
CONSORT Controlled clinical trials (J) 
Cooperative cancer trials 
Cooperative heart disease trials 
Cooperative studies program, US Department of Veterans Affairs 
Cost-effectiveness 
Covariate imbalance, adjustment for 
Crossover designs 
Data and safety monitoring 
Data and safety monitoring boards 
Data management and coordination 
Drug approval and regulation 
Drug interactions 
Eligibility and exclusion criteria 
Equivalence trials 
Ethics 
European Federation of Statisticians in the Pharmaceutical Industry (EPSPI) 
European Organization for Research and Treatment of Cancer (EORTC) 
Factorial designs 
Fraud 
Group-randomization designs 
Guidelines 
Historical controls, bias from 
History, early cancer and heart disease trials 
History, overview 
Intention to treat analysis 
International Studies of Infarct Survival (ISIS) 
Medical ethics and statistics (with new material) 
Medical Research Council (MRC) Streptomycin Trial 
Meta-analysis 
Missing data 
Multicenter trials 
Multiple endpoints 
Multiplicity 
Noncompliance, adjustment for 
Nonrandomized trials 
NSABP and advances in the treatment of breast cancer 
Number needed to treat (NNT) 
Outcome measures 
Pharmaceutical industry, statistics in 
Phase I trials 
Phase II trials 
Physicians' health study 
Postmarketing surveillance of new drugs and assessment of risk 
Preclinical treatment evaluation 
Prevention trials 
Protocols 
QUOROM 
Randomization 
Randomized treatment assignment 
Salk vaccine 
Sample size determination 
Screening trials 
Sequential methods 
Society for Clinical Trials 
Software 
Statistical review for medical journals 
Statistical review for medical journals, guidelines for authors 
Statistician in the pharmaceutical industry (PSI) 
Surrogate endpoints 
Textbooks 
Time-varying treatment effect 
Treatment-covariate interaction 
University Group Diabetes Program (UGDP) 
Vaccine studies 


Main Page for this Work
Table of Contents
About the Editors
Sample Articles


This Web site Copyright ® 1999-2001 John Wiley & Sons, Inc. All rights reserved.